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Dear editor,
We would like to discuss briefly new information regarding the article 
“Evolução do sistema público de saúde no Brasil frente ao estágio 
atual da prevenção do câncer de colo uterino em mulheres jovens e 
adolescentes” (1). 
In 2017, the Ministry of Health of Brazil started to implement the 
quadrivalent vaccination against human papillomavirus (HPV) for 
boys aged 12 to 13 years, thus making Brazil the first South American 
country that offers this vaccine for boys in the National Immunization 
Calendar  through mass vaccination (2,3). In addition, the age group 
for vaccination of children and adolescent girls against HPV was 
extended from 9 to 14 years (2). 
It is worth mentioning that in 2020, the vaccination of boys will 
be done beginning at age 9 (2,3). Today, vaccination against HPV 
is still provided to girls aged 9 to 26 years infected with human 
immunodeficiency virus (HIV), and vaccination to boys with the 
same condition was initiated in 2017 (2). 
All these changes intend to decrease the number of HPV infection 
cases, as well as related deaths (3). However, according to Sanches et 
al. (2017), several barriers have been found that hinder the effective 
implementation of the vaccination against HPV in children and 
adolescents (1). 
In consequence, we believe that improvements are necessary, 
especially regarding health education in schools and specific 
professional training to attend to the needs of this age group. Only 
when these requirements are met, it can be possible to provide 
adequate assistance to these individuals, with a significant increase 
in vaccination rates.
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